The use of immunotherapy as an alternative treatment for cancer patients has become of
great interest in the scientific community as it is required to overcome many of the currently …

Chimeric antigen receptor (CAR)‑T cell therapy is an innovative approach to immune cell
therapy that works by modifying the T cells of a patient to express the CAR protein on their …

Chimeric antigen receptor (CAR) T-cell therapy was envisioned as a mechanism to re-direct
effector T-cells to eliminate tumor cells. CARs are composed of the variable region of an …

Early results from clinical trials of autologous chimeric antigen receptor (CAR)-expressing T
cells for the therapy of B-cell malignancies have encouraged extending the potency of this …

Chimeric antigen receptors (CARs) are a series of manufactured receptors that have the
capacity of binding to specific antigens expressed on surface of tumor cells. A CAR normally …

Immunotherapy has emerged as a potent and effective treatment for multiple cancer types.
For example, the engineering of T cells through the expression of chimeric antigen receptor …

Chimeric antigen receptor (CAR)-T cell therapy is a revolutionary new pillar in cancer
treatment. Although treatment with CAR-T cells has produced remarkable clinical responses …

The field of cancer immunotherapy has been re-energized by the application of chimeric
antigen receptor (CAR) T cell therapy in cancers. These CAR T cells are engineered to …

Immunotherapeutic treatments for malignant cancers have revolutionized the medical and
scientific fields. Lymphocytes engineered to display chimeric antigen receptor (CAR) …

Current cancer treatment strategies have been advanced by chimeric antigen receptor
(CAR) cell therapy, a rapidly emerging cellular immunotherapy. The numerous revolutionary …